Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Placebo-Controlled Phase II Trial Evaluating Safety and Efficacy of Oral Human Immunoglobulin in the Treatment of Gastrointestinal Dysfunction Associated With Autistic Disorder in Pediatric Patients From 2 to 18 Years of Age

NCT00110708 is registered in ClinicalTrials.gov with PediaMed Pharmaceuticals as lead sponsor.

NCT NCT00110708
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00110708 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Placebo-Controlled Phase II Trial Evaluating Safety and Efficacy of Oral Human Immunoglobulin in the Treatment of Gastrointestinal Dysfunction Associated With Autistic Disorder in Pediatric Patients From 2 to 18 Years of Age
Lead sponsor
PediaMed Pharmaceuticals
Phase
Phase 2
Overall status
Unknown status
Start date
April 30, 2005
Completion date
June 30, 2006
Enrollment
120
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

autism, autistic disorder, child development disorders, pervasive, gastrointestinal diseases, signs and symptoms, digestive